HIV phenotype correlates with the relative amounts of lymphocyte function-related molecule 1 (LFA-1) and major histocompatibility complex (MHC) class II in the virion envelope

AIDS

Volumn 14, Issue 11, 2000, Pages 1523-1531

  Lallos, Lisa Bastiani ^a,d   Cecilia, D ^b,e   Fenyö, Eva Maria ^c   Laal, Suman ^a,b   Zolla Pazner, Susan ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e NATIONAL INSTITUTE OF VIROLOGY   (India)

Author keywords

Adhesion molecules; CCR5; CXCR4; HIV phenotype; LFA 1; MHC class II; Virion envelope

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GAG PROTEIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS TYPING;

HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; PHENOTYPE; RECEPTORS, CCR5; RECEPTORS, CXCR4; TUMOR CELLS, CULTURED; VIRION;

EID: 0033821202     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200007280-00008     Document Type: Article

References (36)

1. Immunological and virological markers of disease progression in HIV-infected children
2. Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines
3. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
4. HIV type 1 subtypes, coreceptor usage, and CCR5 polymorphism
5. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection
6. Differential syncytium-inducing capacity of human immunodeficiency virus isolated: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex
7. Replicative capacity, cytopathic effect and cell tropism of HIV
8. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression
9. Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell decline in vivo
10. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
11. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
12. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection
13. Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines
14. Intercellular adhesion molecule 3, a candidate human immunodeficiency virus type 1 co-receptor on lymphoid and monocytoid cells
15. Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation
16. Intercellular adhesion molecules (ICAM)-1 ICAM-2 and ICAM-3 function as counter-receptors for lymphocyte function-associated molecule 1 in human immunodeficiency virus-mediated syncytia formation
17. Human immunodeficiency virus (HIV) infection in CD4+ T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission
18. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity
19. Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization
20. Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity
21. T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1
22. HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells
23. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage
24. Generation of human monoclonal antibodies to human immunodeficiency virus
25. Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions
26. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay
27. MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection
28. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression
29. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system
30. Leucocyte adhesion to cells in immune and inflammatory responses
31. Adhesion molecules on human tonsil dendritic cells
32. The state of differentiation of cultured human keratinocytes determines the level of intercellular adhesion molecule-1 (ICAM-1) expression induced by gamma interferon
33. Isolation and culture of synovial microvascular endothelial cells. Characterization and assessment of adhesion molecule expression
34. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity
35. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific
36. Acquisition of host cell-surface-derived molecules by HIV-1